2008 JASN IMPACT FACTOR 7.505	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2008111157v1 20/8/1805    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Boer, I. H. Articles by Siscovick, D. S. Search for Related Content PubMed PubMed Citation Articles by de Boer, I. H. Articles by Siscovick, D. S. Related Collections Related Articles

25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification

Ian H. de Boer^*,, Bryan Kestenbaum^*,, Abigail B. Shoben, Erin D. Michos, Mark J. Sarnak^|| and David S. Siscovick^*

*Department of Medicine,
Division of Nephrology, and
Department of Biostatistics, University of Washington, Seattle, Washington;
Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and
^||Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts

Correspondence: Dr. Ian H. de Boer, Division of Nephrology, University of Washington, Box 356521, 1959 NE Pacific Street, Seattle, WA 98195. Phone: 206-616-5403; Fax: 206-685-2473; E-mail: deboer{at}u.washington.edu

Received for publication November 10, 2008. Accepted for publication March 17, 2009.

Vitamin D deficiency associates with increased risk for cardiovascular events and mortality, but the mechanism driving this association is unknown. Here, we tested whether circulating 25-hydroxyvitamin D concentration associates with coronary artery calcification (CAC), a measure of coronary atherosclerosis, in the Multi-Ethnic Study of Atherosclerosis. We included 1370 participants: 394 with and 976 without chronic kidney disease (estimated GFR <60 ml/min per 1.73 m²). At baseline, CAC was prevalent among 723 (53%) participants. Among participants free of CAC at baseline, 135 (21%) developed incident CAC during 3 yr of follow-up. Lower 25-hydroxyvitamin D concentration did not associate with prevalent CAC but did associate with increased risk for developing incident CAC, adjusting for age, gender, race/ethnicity, site, season, physical activity, smoking, body mass index, and kidney function. Further adjustment for BP, diabetes, C-reactive protein, and lipids did not alter this finding. The association of 25-hydroxyvitamin D with incident CAC seemed to be stronger among participants with lower estimated GFR. Circulating 1,25-dihydroxyvitamin D concentrations among participants with chronic kidney disease did not significantly associate with prevalent or incident CAC in adjusted models. In conclusion, lower 25-hydroxyvitamin D concentrations associate with increased risk for incident CAC. Accelerated development of atherosclerosis may underlie, in part, the increased cardiovascular risk associated with vitamin D deficiency.

Related Articles

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A12. [Full Text] [PDF]

This article has been cited by other articles:

				I. Bhan and R. Thadhani Vascular Calcification and ESRD: A Hard Target Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S102 - S105. [Abstract] [Full Text] [PDF]

				M. L. Melamed and R. Thadhani Low Calcidiol Levels and Coronary Artery Calcification: True, True, and Related? J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1663 - 1665. [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673